Temasek Holdings plans to triple its AI investments from $25 billion to $75 billion by 2030, joining funding rounds for Anthropic, Waymo, and Isomorphic Labs as part of a broader restructuring to inte…
Google DeepMind's AlphaFold 3 predicts interactions among proteins, DNA, RNA, ligands, and other biomolecules, while Isomorphic Labs introduced the Isomorphic Drug Design Engine (IsoDDE) for drug disc…
Anthropic announced Claude Science, an AI workbench for scientists, and revealed plans to develop its own drugs targeting neglected diseases, marking one of the most direct attempts by a major AI comp…
Eli Lilly invested $40 million in Absci, a generative AI drug company, to develop ABS-201, an injectable antibody for baldness and endometriosis. The deal, part of a $100 million stock offering, aims …
Google Cloud will offer specialist AI models from SandboxAQ, called large quantitative models, through its marketplace, pairing them with Gemini to serve scientific fields like drug discovery and mate…
Isomorphic Labs, a Google DeepMind spinoff, has developed a new AI system called the Isomorphic Drug Design Engine (IsoDDE) to identify hidden binding sites on proteins that standard models like Alpha…
Isomorphic Labs, the AI drug discovery startup spun out of Google DeepMind in 2021, raised a new $2.1 billion Series B led by Thrive Capital to scale its computing power and drug development programs.…
SandboxAQ has partnered with Anthropic to integrate its physics-based AI models, known as Large Quantitative Models (LQMs), into Claude, allowing researchers to perform complex drug discovery and mate…